Search Results - "TRACHSEL, Sissel"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth by Inderberg, Else M., Wälchli, Sébastien, Myhre, Marit R., Trachsel, Sissel, Almåsbak, Hilde, Kvalheim, Gunnar, Gaudernack, Gustav

    Published in Oncoimmunology (03-04-2017)
    “…T-cell receptor (TCR) transfer is an attractive strategy to increase the number of cancer-specific T cells in adoptive cell therapy. However, recent clinical…”
    Get full text
    Journal Article
  2. 2

    Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001 by Inderberg-Suso, Else-Marit, Trachsel, Sissel, Lislerud, Kari, Rasmussen, Anne-Marie, Gaudernack, Gustav

    Published in Oncoimmunology (01-08-2012)
    “…Understanding the basis of a successful clinical response after treatment with therapeutic cancer vaccines is essential for the development of more efficacious…”
    Get full text
    Journal Article
  3. 3

    Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients by KYTE, Jon Amund, GAUDERNACK, Gustav, DUELAND, Svein, TRACHSEL, Sissel, JULSRUD, Lars, AAMDAL, Steinar

    Published in Clinical cancer research (01-07-2011)
    “…The study is a proof-of-principle trial evaluating toxicity, immune response, and clinical response in melanoma patients after combined therapy with…”
    Get full text
    Journal Article
  4. 4

    Telomerase peptide vaccination : a phase I/II study in patients with non-small cell lung cancer by BRUNSVIG, Paal F, AAMDAL, Steinar, GAUDERNACK, Gustav, GJERTSEN, Marianne K, KVALHEIM, Gunnar, MARKOWSKI-GRIMSRUD, Carrie J, SVE, Ingunn, DYRHAUG, Marianne, TRACHSEL, Sissel, MØLLER, Mona, ERIKSEN, Jon A

    Published in Cancer Immunology, Immunotherapy (01-12-2006)
    “…A phase I/II study was conducted to investigate the safety, tolerability and clinical response to vaccination with a combination of telomerase peptides GV1001…”
    Get full text
    Journal Article
  5. 5

    Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination by Kyte, Jon Amund, Trachsel, Sissel, Risberg, Bente, thor Straten, Per, Lislerud, Kari, Gaudernack, Gustav

    Published in Cancer Immunology, Immunotherapy (01-10-2009)
    “…Cancer vaccine trials frequently report on immunological responses, without any clinical benefit. This paradox may reflect the challenge of discriminating…”
    Get full text
    Journal Article
  6. 6

    Vaccination of patients with cutaneous melanoma with telomerase-specific peptides by Hunger, Robert E., Kernland Lang, Kristin, Markowski, Carrie J., Trachsel, Sissel, Møller, Mona, Eriksen, Jon A., Rasmussen, Anne-Marie, Braathen, Lasse R., Gaudernack, Gustav

    Published in Cancer Immunology, Immunotherapy (01-11-2011)
    “…Purpose A phase I study was conducted to investigate the safety, tolerability, and immunological responses to vaccination with a combination of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Noncleavable Transmembrane Mouse Tumor Necrosis Factor-α (TNFα) Mediates Effects Distinct from Those of Wild-type TNFα in Vitro and in Vivo by Christoph Mueller, Nadia Corazza, Sissel Trachsel-Løseth, Hans-Pietro Eugster, Myriam Bühler-Jungo, Thomas Brunner, Martin A. Imboden

    Published in The Journal of biological chemistry (31-12-1999)
    “…Tumor necrosis factor-α (TNFα) exists in two biologically active forms, a 26-kDa transmembrane form and a proteolytically cleaved and secreted form. We…”
    Get full text
    Journal Article
  9. 9

    Noncleavable Transmembrane Mouse Tumor Necrosis Factor-α (TNFα) Mediates Effects Distinct from Those of Wild-type TNFα in Vitro and in Vivo by Mueller, Christoph, Corazza, Nadia, Trachsel-Løseth, Sissel, Eugster, Hans-Pietro, Bühler-Jungo, Myriam, Brunner, Thomas, Imboden, Martin A.

    Published in The Journal of biological chemistry (31-12-1999)
    “…Tumor necrosis factor- alpha (TNF alpha ) exists in two biologically active forms, a 26-kDa transmembrane form and a proteolytically cleaved and secreted form…”
    Get full text
    Journal Article
  10. 10

    Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood by Naume, B, Borgen, E, Beiske, K, Herstad, T K, Ravnås, G, Renolen, A, Trachsel, S, Thrane-Steen, K, Funderud, S, Kvalheim, G

    Published in Journal of hematotherapy (01-04-1997)
    “…Detection of isolated tumor cells (TC) in bone marrow (BM) from patients with breast cancer is usually accomplished by immunocytochemical (ICC) analysis of up…”
    Get more information
    Journal Article